Norovirus: Targets and tools in antiviral drug discovery

Biochemical Pharmacology

Volumn 91, Issue 1, 2014, Pages 1-11

  Rocha Pereira, Joana ^a   Neyts, Johan ^a   Jochmans, Dirk ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Antiviral drugs; Antiviral targets; Cell culture models; Norovirus; Small animal models

Indexed keywords

ANTIVIRUS AGENT; CYSTEINE PROTEINASE; NONSTRUCTURAL PROTEIN 1; NONSTRUCTURAL PROTEIN 2; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4; NONSTRUCTURAL PROTEIN 5; NONSTRUCTURAL PROTEIN 6; NONSTRUCTURAL PROTEIN 7; NOROVIRUS PROTEIN; RNA DIRECTED RNA POLYMERASE; RNA HELICASE; UNCLASSIFIED DRUG; VIRUS PROTEIN; VPG PROTEIN;

AMINO TERMINAL SEQUENCE; ANTIVIRAL ACTIVITY; ARTICLE; CULTURE TECHNIQUE; DRUG TARGETING; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; NOROVIRUS; NOROVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN TARGETING; VACCINE PRODUCTION; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS GENOME; VIRUS LOAD; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANTIVIRAL DRUGS; ANTIVIRAL TARGETS; CELL CULTURE MODELS; NOROVIRUS; SMALL ANIMAL MODELS;

ANIMALS; ANTIVIRAL AGENTS; CALICIVIRIDAE INFECTIONS; CELLS, CULTURED; GASTROENTERITIS; GENETIC VARIATION; HUMANS; MICE; MOLECULAR TARGETED THERAPY; NOROVIRUS; SWINE; VIRAL VACCINES; VIRUS REPLICATION;

EID: 84905501373     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2014.05.021     Document Type: Note

References (100)

1. E. Scallan, R.M. Hoekstra, F.J. Angulo, R.V. Tauxe, M.A. Widdowson, and S.L. Roy et al. Foodborne illness acquired in the United States - major pathogens Emerg Infect Dis 17 2011 7 15
2. L. Liu, H.L. Johnson, S. Cousens, J. Perin, S. Scott, and J.E. Lawn et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000 Lancet 379 2012 2151 2161
3. M.M. Patel, M.A. Widdowson, R.I. Glass, K. Akazawa, J. Vinje, and U.D. Parashar Systematic literature review of role of noroviruses in sporadic gastroenteritis Emerg Infect Dis 14 2008 1224 1231
4. D.C. Payne, J. Vinje, P.G. Szilagyi, K.M. Edwards, M.A. Staat, and G.A. Weinberg et al. Norovirus and medically attended gastroenteritis in U.S. children N Engl J Med 368 2013 1121 1130
5. A.J. Hall, A.T. Curns, L.C. McDonald, U.D. Parashar, and B.A. Lopman The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999-2007 Clin Infect Dis 55 2012 216 223
6. L. van Asten, J. Siebenga, C. van den Wijngaard, R. Verheij, H. van Vliet, and M. Kretzschmar et al. Unspecified gastroenteritis illness and deaths in the elderly associated with norovirus epidemics Epidemiology 22 2011 336 343
7. E. Vega, L. Barclay, N. Gregoricus, S.H. Shirley, D. Lee, and J. Vinje Genotypic and epidemiologic trends of norovirus outbreaks in the United States, 2009 to 2013 J Clin Microbiol 52 2014 147 155
8. S. Hansen, S. Stamm-Balderjahn, I. Zuschneid, M. Behnke, H. Ruden, and R.P. Vonberg et al. Closure of medical departments during nosocomial outbreaks: data from a systematic analysis of the literature J Hosp Infect 65 2007 348 353 (Pubitemid 46477978)
9. J.P. Harris, N.L. Adams, B.A. Lopman, D.J. Allen, and G.K. Adak The development of web-based surveillance provides new insights into the burden of norovirus outbreaks in hospitals in England Epidemiol Infect 142 2014 1590 1598
10. K.Y. Green Caliciviridae: the noroviruses D.M. Knipe, P.M. Howley, Fields virology sixth ed. 2013 Lippincott Williams & Wilkins Philadelphia, PA 583 609
11. B. Zanini, C. Ricci, F. Bandera, F. Caselani, A. Magni, and A.M. Laronga et al. Incidence of post-infectious irritable bowel syndrome and functional intestinal disorders following a water-borne viral gastroenteritis outbreak Am J Gastroenterol 107 2012 891 899
12. S.Y. Chen, C.N. Tsai, M.W. Lai, C.Y. Chen, K.L. Lin, and T.Y. Lin et al. Norovirus infection as a cause of diarrhea-associated benign infantile seizures Clin Infect Dis 48 2009 849 855
13. S. Ito, S. Takeshita, A. Nezu, Y. Aihara, S. Usuku, and Y. Noguchi et al. Norovirus-associated encephalopathy Pediatr Infect Dis J 25 2006 651 652 (Pubitemid 43995368)
14. R.L. Stuart, K. Tan, J.E. Mahar, C.D. Kirkwood, C. Andrew Ramsden, and N. Andrianopoulos et al. An outbreak of necrotizing enterocolitis associated with norovirus genotype GII.3 Pediatr Infect Dis J 29 2010 644 647
15. K. Bok, and K.Y. Green Norovirus gastroenteritis in immunocompromised patients N Engl J Med 367 2012 2126 2132
16. S. Schwartz, M. Vergoulidou, E. Schreier, C. Loddenkemper, M. Reinwald, and M. Schmidt-Hieber et al. Norovirus gastroenteritis causes severe and lethal complications after chemotherapy and hematopoietic stem cell transplantation Blood 117 2011 5850 5856
17. B. Lopman, P. Gastanaduy, G.W. Park, A.J. Hall, U.D. Parashar, and J. Vinje Environmental transmission of norovirus gastroenteritis Curr Opin Virol 2 2012 96 102
18. J.J. Siebenga, M.F. Beersma, H. Vennema, P. van Biezen, N.J. Hartwig, and M. Koopmans High prevalence of prolonged norovirus shedding and illness among hospitalized patients: a model for in vivo molecular evolution J Infect Dis 198 2008 994 1001
19. P.F. Teunis, C.L. Moe, P. Liu, S.E. Miller, L. Lindesmith, and R.S. Baric et al. Norwalk virus: how infectious is it J Med Virol 80 2008 1468 1476
20. A. Kroneman, E. Vega, H. Vennema, J. Vinje, P.A. White, and G. Hansman et al. Proposal for a unified norovirus nomenclature and genotyping Arch Virol 158 2013 2059 2068
21. B.R. Bank-Wolf, M. Konig, and H.J. Thiel Zoonotic aspects of infections with noroviruses and sapoviruses Vet Microbiol 140 2010 204 212
22. L.C. Lindesmith, E.F. Donaldson, A.D. Lobue, J.L. Cannon, D.P. Zheng, and J. Vinje et al. Mechanisms of GII.4 norovirus persistence in human populations PLoS Med 5 2008 e31
23. R.I. Glass, U.D. Parashar, and M.K. Estes Norovirus gastroenteritis N Engl J Med 361 2009 1776 1785
24. L.B. Thackray, C.E. Wobus, K.A. Chachu, B. Liu, E.R. Alegre, and K.S. Henderson et al. Murine noroviruses comprising a single genogroup exhibit biological diversity despite limited sequence divergence J Virol 81 2007 10460 10473 (Pubitemid 47463319)
25. N. McFadden, D. Bailey, G. Carrara, A. Benson, Y. Chaudhry, and A. Shortland et al. Norovirus regulation of the innate immune response and apoptosis occurs via the product of the alternative open reading frame 4 PLoS Pathog 7 2011 e1002413
26. S. Vongpunsawad, Prasad B.V. Venkataram, and M.K. Estes Norwalk virus minor capsid protein VP2 associates within the VP1 shell domain J Virol 87 2013 4818 4825
27. E.F. Donaldson, L.C. Lindesmith, A.D. Lobue, and R.S. Baric Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populations Immunol Rev 225 2008 190 211
28. S.S. El-Kamary, M.F. Pasetti, P.M. Mendelman, S.E. Frey, D.I. Bernstein, and J.J. Treanor et al. Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues J Infect Dis 202 2010 1649 1658
29. M. Tan, P. Huang, M. Xia, P.A. Fang, W. Zhong, and M. McNeal et al. Norovirus P particle, a novel platform for vaccine development and antibody production J Virol 85 2011 753 764
30. R.L. Atmar, D.I. Bernstein, C.D. Harro, M.S. Al-Ibrahim, W.H. Chen, and J. Ferreira et al. Norovirus vaccine against experimental human Norwalk virus illness N Engl J Med 365 2011 2178 2187
31. S.M. Karst, C.E. Wobus, M. Lay, J. Davidson, and H.W.T Virgin STAT1-dependent innate immunity to a Norwalk-like virus Science 299 2003 1575 1578 (Pubitemid 36297707)
32. C.E. Wobus, S.M. Karst, L.B. Thackray, K.O. Chang, S.V. Sosnovtsev, and G. Belliot et al. Replication of Norovirus in cell culture reveals a tropism for dendritic cells and macrophages PLoS Biol 2 2004 e432
33. C.E. Wobus, L.B. Thackray, and H.W. Virgin Murine norovirus: a model system to study norovirus biology and pathogenesis J Virol 80 2006 5104 5112
34. J.M. Ward, C.E. Wobus, L.B. Thackray, C.R. Erexson, L.J. Faucette, and G. Belliot et al. Pathology of immunodeficient mice with naturally occurring murine norovirus infection Toxicol Pathol 34 2006 708 715 (Pubitemid 44665523)
35. E. Duizer, K.J. Schwab, F.H. Neill, R.L. Atmar, M.P. Koopmans, and M.K. Estes Laboratory efforts to cultivate noroviruses J Gen Virol 85 2004 79 87 (Pubitemid 38128872)
36. M.M. Herbst-Kralovetz, A.L. Radtke, M.K. Lay, B.E. Hjelm, A.N. Bolick, and S.S. Sarker et al. Lack of norovirus replication and histo-blood group antigen expression in 3-dimensional intestinal epithelial cells Emerg Infect Dis 19 2013 431 438
37. S. Takanashi, L.J. Saif, J.H. Hughes, T. Meulia, K. Jung, and K.A. Scheuer et al. Failure of propagation of human norovirus in intestinal epithelial cells with microvilli grown in three-dimensional cultures Arch Virol 159 2014 257 266
38. M.K. Lay, R.L. Atmar, S. Guix, U. Bharadwaj, H. He, and F.H. Neill et al. Norwalk virus does not replicate in human macrophages or dendritic cells derived from the peripheral blood of susceptible humans Virology 406 2010 1 11
39. W.K. Leung, P.K. Chan, N.L. Lee, and J.J. Sung Development of an in vitro cell culture model for human noroviruses and its clinical application Hong Kong Med J = Xianggang yi xue za zhi/Hong Kong Acad Med 16 2010 18 21
40. K.O. Chang, S.V. Sosnovtsev, G. Belliot, A.D. King, and K.Y. Green Stable expression of a Norwalk virus RNA replicon in a human hepatoma cell line Virology 353 2006 463 473 (Pubitemid 44419417)
41. S. Taube, A.O. Kolawole, M. Hohne, J.E. Wilkinson, S.A. Handley, and J.W. Perry et al. A mouse model for human norovirus mBio 4 2013 e00450 e513
42. K. Bok, G.I. Parra, T. Mitra, E. Abente, C.K. Shaver, and D. Boon et al. Chimpanzees as an animal model for human norovirus infection and vaccine development Proc Nat Acad Sci USA 108 2011 325 330
43. S. Cheetham, M. Souza, T. Meulia, S. Grimes, M.G. Han, and L.J. Saif Pathogenesis of a genogroup II Human norovirus in gnotobiotic pigs J Virol 80 2006 10372 10381 (Pubitemid 44628885)
44. M. Souza, M.S. Azevedo, K. Jung, S. Cheetham, and L.J. Saif Pathogenesis and immune responses in gnotobiotic calves after infection with the genogroup II.4-HS66 strain of human norovirus J Virol 82 2008 1777 1786 (Pubitemid 351206927)
45. M. Guo, J. Hayes, K.O. Cho, A.V. Parwani, L.M. Lucas, and L.J. Saif Comparative pathogenesis of tissue culture-adapted and wild-type Cowden porcine enteric calicivirus (PEC) in gnotobiotic pigs and induction of diarrhea by intravenous inoculation of wild-type PEC J Virol 75 2001 9239 9251 (Pubitemid 32851927)
46. K. Sestak, S. Feely, B. Fey, J. Dufour, E. Hargitt, and X. Alvarez et al. Experimental inoculation of juvenile rhesus macaques with primate enteric caliciviruses PLoS One 7 2012 e37973
47. S.M. Mumphrey, H. Changotra, T.N. Moore, E.R. Heimann-Nichols, C.E. Wobus, and M.J. Reilly et al. Murine norovirus 1 infection is associated with histopathological changes in immunocompetent hosts, but clinical disease is prevented by STAT1-dependent interferon responses J Virol 81 2007 3251 3263 (Pubitemid 46456634)
48. G. Liu, S.M. Kahan, Y. Jia, and S.M. Karst Primary high-dose murine norovirus 1 infection fails to protect from secondary challenge with homologous virus J Virol 83 2009 6963 6968
49. A. Arias, D. Bailey, Y. Chaudhry, and I. Goodfellow Development of a reverse-genetics system for murine norovirus 3: long-term persistence occurs in the caecum and colon J Gen Virol 93 2012 1432 1441
50. T.J. Nice, D.W. Strong, B.T. McCune, C.S. Pohl, and H.W. Virgin A single-amino-acid change in murine norovirus NS1/2 is sufficient for colonic tropism and persistence J Virol 87 2013 327 334
51. S.M. Kahan, G. Liu, M.K. Reinhard, C.C. Hsu, R.S. Livingston, and S.M. Karst Comparative murine norovirus studies reveal a lack of correlation between intestinal virus titers and enteric pathology Virology 421 2011 202 210
52. D.W. Strong, L.B. Thackray, T.J. Smith, and H.W. Virgin Protruding domain of capsid protein is necessary and sufficient to determine murine norovirus replication and pathogenesis in vivo J Virol 86 2012 2950 2958
53. M. Tan, and X. Jiang Norovirus gastroenteritis, carbohydrate receptors, and animal models PLoS Pathog 6 2010 e1000983
54. M. Tan, and X. Jiang Virus-host interaction and cellular receptors of caliciviruses S. Grant, Hansman XJJaKYG Caliciviruses: molecular and cellular virology 2010 Academic Press Caister 111 130
55. G.S. Hansman, S. Shahzad-Ul-Hussan, J.S. McLellan, G.Y. Chuang, I. Georgiev, and T. Shimoike et al. Structural basis for norovirus inhibition and fucose mimicry by citrate J Virol 86 2012 284 292
56. X.F. Zhang, M. Tan, M. Chhabra, Y.C. Dai, J. Meller, and X. Jiang Inhibition of histo-blood group antigen binding as a novel strategy to block norovirus infections PLoS One 8 2013 e69379
57. L. Han, E.N. Kitova, M. Tan, X. Jiang, and J.S. Klassen Identifying carbohydrate ligands of a norovirus P particle using a catch and release electrospray ionization mass spectrometry assay J Am Soc Mass Spectrom 25 2014 111 119
58. J. Shang, V.E. Piskarev, M. Xia, P. Huang, X. Jiang, and L.M. Likhosherstov et al. Identifying human milk glycans that inhibit norovirus binding using surface plasmon resonance Glycobiology 23 2013 1491 1498
59. A. Gerondopoulos, T. Jackson, P. Monaghan, N. Doyle, and L.O. Roberts Murine norovirus-1 cell entry is mediated through a non-clathrin-, non-caveolae-, dynamin- and cholesterol-dependent pathway J Gen Virol 91 2010 1428 1438
60. J.W. Perry, and C.E. Wobus Endocytosis of murine norovirus 1 into murine macrophages is dependent on dynamin II and cholesterol J Virol 84 2010 6163 6176
61. K.O. Chang Role of cholesterol pathways in norovirus replication J Virol 83 2009 8587 8595
62. K. Jung, Q. Wang, Y. Kim, K. Scheuer, Z. Zhang, and Q. Shen et al. The effects of simvastatin or interferon-alpha on infectivity of human norovirus using a gnotobiotic pig model for the study of antivirals PLoS One 7 2012 e41619
63. J.W. Perry, S. Taube, and C.E. Wobus Murine norovirus-1 entry into permissive macrophages and dendritic cells is pH-independent Virus Res 143 2009 125 129
64. J.L. Hyde, S.V. Sosnovtsev, K.Y. Green, C. Wobus, H.W. Virgin, and J.M. Mackenzie Mouse norovirus replication is associated with virus-induced vesicle clusters originating from membranes derived from the secretory pathway J Virol 83 2009 9709 9719
65. V. Fernandez-Vega, S.V. Sosnovtsev, G. Belliot, A.D. King, T. Mitra, and A. Gorbalenya et al. Norwalk virus N-terminal nonstructural protein is associated with disassembly of the Golgi complex in transfected cells J Virol 78 2004 4827 4837 (Pubitemid 38501103)
66. J.L. Hyde, and J.M. Mackenzie Subcellular localization of the MNV-1 ORF1 proteins and their potential roles in the formation of the MNV-1 replication complex Virology 406 2010 138 148
67. B.N. Borin, W. Tang, T.J. Nice, B.T. McCune, H.W. Virgin, and A.M. Krezel Murine norovirus protein NS1/2 aspartate to glutamate mutation, sufficient for persistence, reorients side chain of surface exposed tryptophan within a novel structured domain Proteins 82 2014 1200 1209
68. T. Pfister, and E. Wimmer Polypeptide p41 of a Norwalk-like virus is a nucleic acid-independent nucleoside triphosphatase J Virol 75 2001 1611 1619 (Pubitemid 32110150)
69. A.M. De Palma, W. Heggermont, K. Lanke, B. Coutard, M. Bergmann, and A.M. Monforte et al. The thiazolobenzimidazole TBZE-029 inhibits enterovirus replication by targeting a short region immediately downstream from motif C in the nonstructural protein 2C J Virol 82 2008 4720 4730 (Pubitemid 351657034)
70. H. Norder, A.M. De Palma, B. Selisko, L. Costenaro, N. Papageorgiou, and C. Arnan et al. Picornavirus non-structural proteins as targets for new anti-virals with broad activity Antiviral Res 89 2011 204 218
71. T. Sara, R. Konrat, and T. Skern Strategies for purifying variants of human rhinovirus 14 2C protein Protein Expr Purif 95 2014 28 37
72. H.J. Thibaut, Y. Malpani, S.H. Ahn, C.K. Lee, A. Tijsma, and E. Verbeken et al. A novel class of highly potent small molecule inhibitors of entero/rhinovirus replication with an excellent safety and pharmacokinetic profile are highly effective against enterovirus infections in mice 26th International Conference on Antiviral Research San Francisco, CA, USA 2013 O123
73. T.M. Sharp, S.E. Crawford, N.J. Ajami, F.H. Neill, R.L. Atmar, and K. Katayama et al. Secretory pathway antagonism by calicivirus homologues of Norwalk virus nonstructural protein p22 is restricted to noroviruses Virol J 9 2012 181
74. N.Y. Hsu, O. Ilnytska, G. Belov, M. Santiana, Y.H. Chen, and P.M. Takvorian et al. Viral reorganization of the secretory pathway generates distinct organelles for RNA replication Cell 141 2010 799 811
75. A.M. De Palma, H.J. Thibaut, L. van der Linden, K. Lanke, W. Heggermont, and S. Ireland et al. Mutations in the nonstructural protein 3A confer resistance to the novel enterovirus replication inhibitor TTP-8307 Antimicrob Agents Chemother 53 2009 1850 1857
76. I. Goodfellow The genome-linked protein VPg of vertebrate viruses - a multifaceted protein Curr Opin Virol 1 2011 355 362
77. E.N. Leen, K.Y. Kwok, J.R. Birtley, P.J. Simpson, C.V. Subba-Reddy, and Y. Chaudhry et al. Structures of the compact helical core domains of feline calicivirus and murine norovirus VPg proteins J Virol 87 2013 5318 5330
78. R. Gingras, K. Mekhssian, C. Fenwick, P.W. White, and D. Thibeault Human rhinovirus VPg uridylylation AlphaScreen for high-throughput screening J Biomol Screen 19 2014 259 269
79. C.E. Zeitler, M.K. Estes, and B.V. Venkataram Prasad X-ray crystallographic structure of the Norwalk virus protease at 1.5-A resolution J Virol 80 2006 5050 5058
80. D. Takahashi, Y. Kim, S. Lovell, O. Prakash, W.C. Groutas, and K.O. Chang Structural and inhibitor studies of norovirus 3C-like proteases Virus Res 178 2013 437 444
81. R.J. Hussey, L. Coates, R.S. Gill, P.T. Erskine, S.F. Coker, and E. Mitchell et al. A structural study of norovirus 3C protease specificity: binding of a designed active site-directed peptide inhibitor Biochemistry 50 2011 240 249
82. Z. Muhaxhiri, L. Deng, S. Shanker, B. Sankaran, M.K. Estes, and T. Palzkill et al. Structural basis of substrate specificity and protease inhibition in Norwalk virus J Virol 87 2013 4281 4292
83. Y. Kim, S. Lovell, K.C. Tiew, S.R. Mandadapu, K.R. Alliston, and K.P. Battaile et al. Broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, noroviruses, and coronaviruses J Virol 86 2012 11754 11762
84. T. Oka, H. Takagi, Y. Tohya, K. Murakami, N. Takeda, and T. Wakita et al. Bioluminescence technologies to detect calicivirus protease activity in cell-free system and in infected cells Antiviral Res 90 2011 9 16
85. I. Alam, J.H. Lee, K.J. Cho, K.R. Han, J.M. Yang, and M.S. Chung et al. Crystal structures of murine norovirus-1 RNA-dependent RNA polymerase in complex with 2-thiouridine or ribavirin Virology 426 2012 143 151
86. D.F. Zamyatkin, F. Parra, J.M. Alonso, D.A. Harki, B.R. Peterson, and P. Grochulski et al. Structural insights into mechanisms of catalysis and inhibition in Norwalk virus polymerase J Biol Chem 283 2008 7705 7712
87. D.F. Zamyatkin, F. Parra, A. Machin, P. Grochulski, and K.K. Ng Binding of 2′-amino-2′-deoxycytidine-5′-triphosphate to norovirus polymerase induces rearrangement of the active site J Mol Biol 390 2009 10 16
88. E. Mastrangelo, M. Pezzullo, D. Tarantino, R. Petazzi, F. Germani, and D. Kramer et al. Structure-based inhibition of Norovirus RNA-dependent RNA polymerases J Mol Biol 419 2012 198 210
89. D. Tarantino, M. Pezzullo, E. Mastrangelo, R. Croci, J. Rohayem, and I. Robel et al. Naphthalene-sulfonate inhibitors of human norovirus RNA-dependent RNA-polymerase Antiviral Res 102 2014 23 28
90. P. Simmonds, I. Karakasiliotis, D. Bailey, Y. Chaudhry, D.J. Evans, and I.G. Goodfellow Bioinformatic and functional analysis of RNA secondary structure elements among different genera of human and animal caliciviruses Nucleic Acids Res 36 2008 2530 2546 (Pubitemid 351659569)
91. S. Vashist, L. Urena, Y. Chaudhry, and I. Goodfellow Identification of RNA-protein interaction networks involved in the norovirus life cycle J Virol 86 2012 11977 11990
92. J. Ye, C. Wang, R. Sumpter Jr., M.S. Brown, J.L. Goldstein, and M. Gale Jr. Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation Proc Nat Acad Sci USA 100 2003 15865 15870 (Pubitemid 38021081)
93. K.O. Chang, S.V. Sosnovtsev, G. Belliot, Y. Kim, L.J. Saif, and K.Y. Green Bile acids are essential for porcine enteric calicivirus replication in association with down-regulation of signal transducer and activator of transcription 1 Proc Nat Acad Sci USA 101 2004 8733 8738 (Pubitemid 38745840)
94. T. Bui, J. Kocher, Y. Li, K. Wen, G. Li, and F. Liu et al. Median infectious dose of human norovirus GII.4 in gnotobiotic pigs is decreased by simvastatin treatment and increased by age J Gen Virol 94 2013 2005 2016
95. M. Rondy, M. Koopmans, C. Rotsaert, T. Van Loon, B. Beljaars, and G. Van Dijk et al. Norovirus disease associated with excess mortality and use of statins: a retrospective cohort study of an outbreak following a pilgrimage to Lourdes Epidemiol Infect 139 2011 453 463
96. C.C. Hsu, L.K. Riley, H.M. Wills, and R.S. Livingston Persistent infection with and serologic cross-reactivity of three novel murine noroviruses Comp Med 56 2006 247 251 (Pubitemid 44299965)
97. T. Farkas, R.W. Cross, E. Hargitt 3rd, N.W. Lerche, A.L. Morrow, and K. Sestak Genetic diversity and histo-blood group antigen interactions of rhesus enteric caliciviruses J Virol 84 2010 8617 8625
98. J. Rocha-Pereira, D. Jochmans, K. Dallmeier, P. Leyssen, R. Cunha, and I. Costa et al. Inhibition of norovirus replication by the nucleoside analogue 2′-C-methylcytidine Biochem Biophys Res Commun 427 2012 796 800
99. V.P. Costantini, T. Whitaker, L. Barclay, D. Lee, T.R. McBrayer, and R.F. Schinazi et al. Antiviral activity of nucleoside analogues against norovirus Antiviral Ther 17 2012 981 991
100. J. Rocha-Pereira, D. Jochmans, K. Dallmeier, P. Leyssen, M.S. Nascimento, and J. Neyts Favipiravir (T-705) inhibits in vitro norovirus replication Biochem Biophys Res Commun 424 2012 777 780